Mounjaro News

Eli Lilly Revenue Climbs on Demand for Obesity Drugs - WSJ

Eli Lilly Revenue Climbs on Demand for Obesity Drugs WSJ

GLP-1-driven vitamin deficiency linked to rare brain disorder: Study - NewsNation

GLP-1-driven vitamin deficiency linked to rare brain disorder: Study NewsNation

Weight-loss drugs in sport: Ozempic, Mounjaro not on Wada banned list for athletes - BBC

Weight-loss drugs in sport: Ozempic, Mounjaro not on Wada banned list for athletes BBC

Injecting to crush kilos: The rise of ‘Mounjaro’ brides - The Times of India

Injecting to crush kilos: The rise of ‘Mounjaro’ brides The Times of India

I was so fat doctors told me they couldn't X-ray me - now I've lost 11st thanks to Mounjaro, it's saved my life - The Irish Sun

I was so fat doctors told me they couldn't X-ray me - now I've lost 11st thanks to Mounjaro, it's saved my life The Irish Sun

Mounjaro rollout on NHS needs 'urgent' boost, say MPs - Sky News

Mounjaro rollout on NHS needs 'urgent' boost, say MPs Sky News

Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition - The Conversation

Started a GLP-1 drug like Ozempic or Mounjaro? Here’s what you need to know about nutrition The Conversation

Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump - Reuters

Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters

Eli Lilly Soars 5% as Mounjaro and Zepbound Demand Drives $5.5 Billion Guidance Raise - Yahoo Finance

Eli Lilly Soars 5% as Mounjaro and Zepbound Demand Drives $5.5 Billion Guidance Raise Yahoo Finance

does bluechew offer weight loss drugs like ozempic wegovy mounjaro: Uses, Safety and What to Know - ΕΜΥ

does bluechew offer weight loss drugs like ozempic wegovy mounjaro: Uses, Safety and What to Know ΕΜΥ

GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level - MassLive.com

GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level MassLive.com

Eli Lilly: Mounjaro And Zepbound Keep The Growth Story Alive (NYSE:LLY) - Seeking Alpha

Eli Lilly: Mounjaro And Zepbound Keep The Growth Story Alive (NYSE:LLY) Seeking Alpha

Dzulkefly: No special Budget 2026 allocation for Ozempic, Mounjaro treatments - The Malaysian Reserve

Dzulkefly: No special Budget 2026 allocation for Ozempic, Mounjaro treatments The Malaysian Reserve

First Homegrown Obesity Drug Undercuts Wegovy and Mounjaro on Price - Koreabizwire

First Homegrown Obesity Drug Undercuts Wegovy and Mounjaro on Price Koreabizwire

Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion - CNBC

Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion CNBC

GLP-1 obesity drugs cut type 2 diabetes risk in prediabetes - DongA Science

GLP-1 obesity drugs cut type 2 diabetes risk in prediabetes DongA Science

Give more people weight-loss jabs on the NHS, say MPs - BBC

Give more people weight-loss jabs on the NHS, say MPs BBC

Lilly's obesity drug strength fuels record rally, Wall Street optimism - Reuters

Lilly's obesity drug strength fuels record rally, Wall Street optimism Reuters

Eli Lilly Raises 2026 Sales Outlook on Mounjaro, Zepbound Strength - Yahoo Finance

Eli Lilly Raises 2026 Sales Outlook on Mounjaro, Zepbound Strength Yahoo Finance

Mounjaro Weight Loss Drug: Understanding Its Role and Evidence for Weight Management - emy

Mounjaro Weight Loss Drug: Understanding Its Role and Evidence for Weight Management emy

Weight-loss drugs fuel protein boom, but with more consumer scrutiny - Reuters

Weight-loss drugs fuel protein boom, but with more consumer scrutiny Reuters

Mounjaro Weight Loss Trial: What the Research Shows About Its Effects - EMY

Mounjaro Weight Loss Trial: What the Research Shows About Its Effects EMY

Weight Loss Diabetes Drug Mounjaro: Understanding Its Role and Considerations - EMY

Weight Loss Diabetes Drug Mounjaro: Understanding Its Role and Considerations EMY

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters

Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat - Science Daily

Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat Science Daily

Eli Lilly Stock Jumps on Monster Earnings as Finance Chief Eyes Next Growth Engine - Barron's

Eli Lilly Stock Jumps on Monster Earnings as Finance Chief Eyes Next Growth Engine Barron's

Eli Lilly's diabetes drug Mounjaro gets approval for a new use - USA Today

Eli Lilly's diabetes drug Mounjaro gets approval for a new use USA Today

FDA Approves Mounjaro to Help Lower Heart Attack and Stroke Risk in Adults With Type 2 Diabetes - WebMD

FDA Approves Mounjaro to Help Lower Heart Attack and Stroke Risk in Adults With Type 2 Diabetes WebMD

Obesity Drugs, Starvation Lead to Malnutrition in 20s, 30s - 조선일보

Obesity Drugs, Starvation Lead to Malnutrition in 20s, 30s 조선일보

Higher Ozempic Dose vs. Mounjaro: Which is Better For Heart Health? - Healthline

Higher Ozempic Dose vs. Mounjaro: Which is Better For Heart Health? Healthline

Mounjaro Approved to Reduce Cardiovascular Risk in Type 2 Diabetes - DocWireNews

Mounjaro Approved to Reduce Cardiovascular Risk in Type 2 Diabetes DocWireNews

I got pregnant while taking Mounjaro. I’m not alone - The Times

I got pregnant while taking Mounjaro. I’m not alone The Times

Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio - Eli Lilly

Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio Eli Lilly

Kim Jun-ho succeeds with a ‘Mounjaro diet’... a 5-kg-lighter look that even Kim Ji-min would fall for (Hit and Miss Tour) - 스포츠조선

Kim Jun-ho succeeds with a ‘Mounjaro diet’... a 5-kg-lighter look that even Kim Ji-min would fall for (Hit and Miss Tour) 스포츠조선

Aspen sees Mounjaro Africa sales above $124 million in 2027 - Reuters

Aspen sees Mounjaro Africa sales above $124 million in 2027 Reuters

Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity - Inside INdiana Business

Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity Inside INdiana Business